Opinion
Video
Author(s):
Drs Helfand, Chapin, and Collins, review the case of 67-year-old man treated with recurring prostate cancer.
Study to evaluate impact of ArteraAI on clinical decision-making for prostate cancer
Pearls & Perspectives: Helen Bernie, DO, MPH, at AUA 2025
AI-based tool aims to optimize MRI use in prostate cancer diagnosis
Dr. Murphy on increasing diversity in cancer clinical trials
Phase 1 study launches for novel CYP11A1 inhibitor for mCRPC
Prostate cancer awareness in 2025: A human imperative in the wake of President Biden’s diagnosis